Payment Networks

Showing 463 articles
Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.

Business

Warsh Nomination Sparks Dollar Surge, Sends Precious Metals Tumbling

The U.S. dollar staged a sharp rally Friday, while gold and silver prices plunged, following President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank. The move, interpreted as a hawkish signal for monetary policy, combined with strong economic data to reshape market expectations.